"10.1371_journal.pone.0045609","none","2012-09-21T00:00:00Z","Michael Wetter; David Goulding; Derek Pickard; Michael Kowarik; Charles J Waechter; Gordon Dougan; Michael Wacker","GlycoVaxyn AG, Schlieren, Switzerland; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom; Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America","Conceived and designed the experiments: M. Wetter MK CJW GD M. Wacker. Performed the experiments: M. Wetter DG DP. Analyzed the data: M. Wetter DG DP CJW GD M. Wacker. Contributed reagents/materials/analysis tools: M. Wetter DG DP MK CJW. Wrote the paper: M. Wetter GD M. Wacker.","The authors have read the journals policy and have the following conflicts: M. Wetter, MK and M. Wacker are all GlycoVaxyn AG employees. M. Wetter, MK and M. Wacker own shares/stock options from GlycoVaxyn AG, and GlycoVaxyn AG was the funder for this study. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","09","Michael Wetter","MW",7,TRUE,1,1,1,1,TRUE,TRUE,TRUE,4,"2;3;5;6",TRUE
